Softwr

Healthcare · head to head

Kareo Clinical vs Lunit

Kareo Clinical logo

Kareo Clinical

Healthcare

Specialized EHR and practice management for independent and small practices

From
$89/month
Rated
-
Full reviewWebsite
Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Kareo Clinical kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product; Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • They diverge on capability: Kareo Clinical covers Electronic Health Records, Lunit covers Lunit INSIGHT MMG.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Kareo Clinical and Lunit actually diverge.

Attributes where Kareo Clinical and Lunit differ
AttributeKareo ClinicalLunit
Starting price$89/monthOn request
Pricing modelsubscriptionquote
PlatformsWeb, MobileWeb
Founded2010Unknown

Identical on both: free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Kareo Clinical

  • Electronic Health Records
  • Scheduling
  • Patient Portal
  • Medical Billing
  • ePrescribing
  • Analytics
  • Labs
  • Pharmacies

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

What people use each for

The jobs each tool is most often brought in to do.

Kareo Clinical

  • Practice management, scheduling and billing for independent medical practicesnot Lunit
  • Electronic health records and e-prescribing for small clinicsnot Lunit
  • Insurance claim submission and patient payment collectionnot Lunit

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Kareo Clinical
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Kareo Clinical
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Kareo Clinical
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Kareo Clinical

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Kareo Clinical

  • Kareo is now part of Tebra and sold under the Tebra brand rather than as a standalone product
  • Tebra publishes no rate: pricing varies with provider count, features and implementation requirements and is quoted during a demo
  • Billing counts clinical providers such as MDs, DOs, NPs and PAs, so adding a prescriber raises the bill even though non clinical staff are free
  • Electronic prescribing of controlled substances setup costs about $75 per provider as a one time fee
  • PDMP integration costs $500 one time per facility plus about $50 per user per year

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Pricing, plan by plan

Kareo Clinical

$89/month
  • Clinical Starter$89/month
    • EHR
    • Scheduling
    • Patient Portal
  • Clinical Plus$189/month
    • Everything in Starter
    • Billing
    • Analytics

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Which should you pick?

Choose Kareo Clinical if

  • You need electronic health records.
  • You work on Web, Mobile.
  • You also want scheduling.
Kareo Clinical review

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Questions people ask

Is Kareo Clinical or Lunit better?
Neither clearly leads. Kareo Clinical starts at $89/month and Lunit at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Kareo Clinical or Lunit?
Kareo Clinical starts at $89/month and Lunit at On request.
Does Kareo Clinical or Lunit run on more platforms?
Kareo Clinical runs on Web, Mobile. Lunit runs on Web.
What is Kareo Clinical best used for?
Kareo Clinical is most often used for practice management, scheduling and billing for independent medical practices, electronic health records and e-prescribing for small clinics, insurance claim submission and patient payment collection. Of those, practice management, scheduling and billing for independent medical practices and electronic health records and e-prescribing for small clinics are not what Lunit is typically brought in for.
What can Kareo Clinical do that Lunit cannot?
Kareo Clinical covers Electronic Health Records, Scheduling, Patient Portal, Medical Billing. Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment.

Answered from the vendors’ own pages

Kareo Clinical: How much does Kareo Clinical (now Tebra) cost?

Kareo Clinical pricing is not published publicly. Pricing is based on the number of clinical providers in your practice, not seat licenses. Setup includes optional EPCS at $75/provider and PDMP Integration at $500 one-time per facility plus $50/user/year.

Source
Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Kareo Clinical: Does Tebra charge for front desk staff and medical assistants?

No. Tebra provides unlimited non-clinical staff access at no extra cost. Front desk staff, medical assistants, billers, and office admins can all access scheduling, charting, and claims modules without increasing billing.

Source
Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Kareo Clinical: Are there reduced rates for low-volume practices on Tebra?

Yes. Practices with providers billing under 100 claims monthly receive lower-tier pricing for those low-volume providers.

Source
Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

More on Kareo Clinical

More on Lunit

Keep looking

Other head to heads